3902 Stock Overview
Develops, produces, maintains, and sells medical information integration systems in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Medical Data Vision Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥383.00 |
| 52 Week High | JP¥625.00 |
| 52 Week Low | JP¥332.00 |
| Beta | 0 |
| 1 Month Change | -9.67% |
| 3 Month Change | -12.76% |
| 1 Year Change | -20.70% |
| 3 Year Change | -56.87% |
| 5 Year Change | -63.83% |
| Change since IPO | -19.47% |
Recent News & Updates
Medical Data Vision Co., Ltd. (TSE:3902) Soars 28% But It's A Story Of Risk Vs Reward
May 07
Calculating The Intrinsic Value Of Medical Data Vision Co., Ltd. (TSE:3902)
Apr 15Recent updates
Medical Data Vision Co., Ltd. (TSE:3902) Soars 28% But It's A Story Of Risk Vs Reward
May 07Calculating The Intrinsic Value Of Medical Data Vision Co., Ltd. (TSE:3902)
Apr 15Medical Data Vision Co., Ltd. (TSE:3902) Stocks Pounded By 30% But Not Lagging Industry On Growth Or Pricing
Mar 08Is Now The Time To Look At Buying Medical Data Vision Co., Ltd. (TSE:3902)?
Feb 11Revenues Not Telling The Story For Medical Data Vision Co., Ltd. (TSE:3902) After Shares Rise 29%
Jan 22Some Investors May Be Worried About Medical Data Vision's (TSE:3902) Returns On Capital
Jan 10Medical Data Vision (TSE:3902) Is Due To Pay A Dividend Of ¥6.50
Dec 20Medical Data Vision (TSE:3902) Will Pay A Dividend Of ¥6.50
Nov 15Medical Data Vision (TSE:3902) Will Pay A Dividend Of ¥6.50
Oct 03Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50
Sep 19Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50
Aug 10Medical Data Vision Co., Ltd. (TSE:3902) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable
Jun 25Why Medical Data Vision Co., Ltd. (TSE:3902) Could Be Worth Watching
Jun 13Shareholder Returns
| 3902 | JP Healthcare Services | JP Market | |
|---|---|---|---|
| 7D | -1.3% | -0.9% | -1.1% |
| 1Y | -20.7% | 16.2% | 0.4% |
Return vs Industry: 3902 underperformed the JP Healthcare Services industry which returned 16.2% over the past year.
Return vs Market: 3902 underperformed the JP Market which returned 0.4% over the past year.
Price Volatility
| 3902 volatility | |
|---|---|
| 3902 Average Weekly Movement | 7.4% |
| Healthcare Services Industry Average Movement | 6.3% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in JP Market | 9.4% |
| 10% least volatile stocks in JP Market | 3.1% |
Stable Share Price: 3902's share price has been volatile over the past 3 months compared to the JP market.
Volatility Over Time: 3902's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 315 | Hiroyuki Iwasaki | www.mdv.co.jp |
Medical Data Vision Co., Ltd. develops, produces, maintains, and sells medical information integration systems in Japan. The company offers data network services; data utilization services; MDV act, an analysis application that enables hospitals to preview hospital management indicators; and Karteco, a personal health record enables users to independently manage their health and medical information. It also provides research, and consulting services for various medical data; business consulting services for medical institutions; and operation and related service of various medical data.
Medical Data Vision Co., Ltd. Fundamentals Summary
| 3902 fundamental statistics | |
|---|---|
| Market cap | JP¥14.50b |
| Earnings (TTM) | -JP¥762.86m |
| Revenue (TTM) | JP¥6.05b |
Is 3902 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3902 income statement (TTM) | |
|---|---|
| Revenue | JP¥6.05b |
| Cost of Revenue | JP¥1.68b |
| Gross Profit | JP¥4.37b |
| Other Expenses | JP¥5.13b |
| Earnings | -JP¥762.86m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -20.15 |
| Gross Margin | 72.24% |
| Net Profit Margin | -12.61% |
| Debt/Equity Ratio | 0% |
How did 3902 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/22 18:05 |
| End of Day Share Price | 2025/05/22 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medical Data Vision Co., Ltd. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yushi Kawamoto | Haitong International Research Limited |
| Masatoshi Nagata | Ichiyoshi Research Institute Inc. |
| Hangil Moon | Jefferies LLC |